Marcelli Pascal-Rodriguez, PMHNP-BC
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,261 | 130 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $698.20 | 51 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $289.79 | 12 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $288.36 | 13 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $215.24 | 16 | $0 (2022) |
| ITI, Inc. | $123.24 | 6 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $108.39 | 5 | $0 (2023) |
| Corium, LLC | $70.82 | 3 | $0 (2023) |
| Tris Pharma Inc | $67.21 | 3 | $0 (2023) |
| Alkermes, Inc. | $62.39 | 3 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $49.45 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $451.15 | 23 | ABBVIE INC. ($225.89) |
| 2023 | $928.74 | 47 | Otsuka America Pharmaceutical, Inc. ($259.43) |
| 2022 | $499.49 | 38 | ABBVIE INC. ($163.82) |
| 2021 | $381.20 | 22 | Sunovion Pharmaceuticals Inc. ($135.81) |
All Payment Transactions
130 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.86 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: PSYCHIATRY | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: NEUROSCIENCE | ||||||
| 07/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $87.82 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $31.96 | General |
| Category: Neuroscience | ||||||
| 04/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: CNS | ||||||
| 04/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.96 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 02/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Neuroscience | ||||||
| 01/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Neuroscience | ||||||
| 12/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 30 | 139 | $23,109 | $7,496 |
| 2022 | 1 | 35 | 156 | $23,497 | $9,372 |
| 2021 | 3 | 144 | 297 | $41,355 | $13,956 |
| 2020 | 3 | 173 | 475 | $61,961 | $26,169 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 139 | $23,109 | $7,496 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 156 | $23,497 | $9,372 | 39.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 174 | $26,100 | $9,353 | 35.8% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 59 | 108 | $11,880 | $3,688 | 31.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $3,375 | $914.96 | 27.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 66 | 223 | $33,301 | $13,074 | 39.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 71 | 216 | $20,560 | $9,846 | 47.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 36 | 36 | $8,100 | $3,249 | 40.1% |
About Marcelli Pascal-Rodriguez, PMHNP-BC
Marcelli Pascal-Rodriguez, PMHNP-BC is a Psychiatric/Mental Health healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2017. The National Provider Identifier (NPI) number assigned to this provider is 1518480045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marcelli Pascal-Rodriguez, PMHNP-BC has received a total of $2,261 in payments from pharmaceutical and medical device companies, with $451.15 received in 2024. These payments were reported across 130 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,261).
As a Medicare-enrolled provider, Pascal-Rodriguez has provided services to 382 Medicare beneficiaries, totaling 1,067 services with total Medicare billing of $56,994. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Virginia Beach, VA
- Active Since 07/17/2017
- Last Updated 01/29/2020
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1518480045
Products in Payments
- VRAYLAR (Drug) $698.20
- SPRAVATO (Drug) $220.38
- LATUDA (Drug) $215.24
- ABILIFY ASIMTUFII (Drug) $124.93
- CAPLYTA (Drug) $123.24
- TRINTELLIX (Drug) $108.39
- ABILIFY MAINTENA (Drug) $98.58
- REXULTI (Drug) $90.88
- INVEGA SUSTENNA (Drug) $69.41
- Dyanavel XR (Drug) $67.21
- ARISTADA (Drug) $62.39
- Azstarys (Drug) $53.60
- INGREZZA (Drug) $49.45
- JORNAY PM (Drug) $45.82
- GRALISE (Drug) $40.32
- QELBREE (Drug) $37.24
- Nuedexta (Drug) $33.63
- QUVIVIQ (Drug) $31.28
- AUSTEDO (Drug) $29.53
- AZSTARYS (Drug) $17.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Virginia Beach
Genise Binns
Psychiatric/Mental Health — Payments: $10,066
Mrs. Nakeshia Mouzon, Fnp, Pmhnp, FNP, PMHNP
Psychiatric/Mental Health — Payments: $6,575
Mary Crutchfield, Pmhnp, Fnp, PMHNP, FNP
Psychiatric/Mental Health — Payments: $6,091
Mrs. Arnella Edwards
Psychiatric/Mental Health — Payments: $5,663
Jamie Deputy, Msn, Aprn, Pmhnp-Bc, MSN, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $4,582
Brittany Smith, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $4,301